Teva’s MSA Drug Emrusolmin Gets FDA Fast Track Designation
Teva’s emrusolmin (TEV-56286), a small-molecule modulator of pathogenic alpha-synuclein oligomers, has received FDA Fast Track designation for multiple system...
CHO Plus Obtains Patent for Improved Yeast Protein Production
CHO Plus has secured U.S. Patent No. 12,404,502 for a yeast cell–fusion platform designed to create hybrid strains with...
Avicanna Announces Change of Chief Financial Officer
Avicanna has appointed Nick Hilborn, CPA, CA, as interim chief financial officer, effective September 15, 2025, as former CFO...
Virbac’s 2025 Semi-Annual Results: A Professional Review
Virbac reported first-half 2025 results showing steady top-line expansion and softer profitability, while reaffirming full-year guidance and signaling a...
Virbac Announces 2025 Half-Year Financial Results
Virbac reported first-half 2025 revenue of €738.3 million, up 5.0% reported and 7.8% at constant exchange rates, with organic...
Theratechnologies Shareholders Approve Future Pak Acquisition
Theratechnologies shareholders have approved a plan of arrangement under Québec law for the company to be acquired by CB...
Gelteq Tech Powers U.S. Nutraceutical Product Launches
Gelteq has moved from development to commercialization in the United States, as products from Healthy Extracts using Gelteq’s proprietary...
BiomX CEO in Spotlight at Wainwright Investment Conference
BiomX will spotlight positive topline Phase 2 data for BX211, a bacteriophage-based therapy targeting Staphylococcus aureus in diabetic foot...
CorMedix Announces Valuable New Strategic Investment in Talphera
CorMedix has taken a $5 million strategic minority stake in Talphera, purchasing 9.09 million shares at $0.55 in a...
Urogen Pharma Announces Inducement Grants Under Nasdaq Rule
UroGen Pharma has granted inducement restricted stock units to 40 new employees, issuable for up to 67,700 ordinary shares,...